Xigris (Zy-gris, drotrecogin alfa), the first drug approved for treating severe sepsis

Lilly is now marketing Xigris (Zy-gris, drotrecogin alfa), the first drug approved for treating severe sepsis.

Until now the main treatment for severe sepsis was antibiotics.

Xigris is the first drug shown to improve survival in cases of severe septic infections. It reduces deaths by about 20%...or saves one life for every 5 patients who would have died.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote